Urinary Neutrophil Gelatinase-Associated Lipocalin as Predictor for Development of Hepatorenal Syndrome in Patients with Hepatic Cirrhosis
Shawky, J., Khorshed, S., Labib, H. (2014). Urinary Neutrophil Gelatinase-Associated Lipocalin as Predictor for Development of Hepatorenal Syndrome in Patients with Hepatic Cirrhosis. EKB Journal Management System, 4(3), 143-148. doi: 10.21608/aeji.2014.17193
Jihan A Shawky; Soha E Khorshed; Hany A Labib. "Urinary Neutrophil Gelatinase-Associated Lipocalin as Predictor for Development of Hepatorenal Syndrome in Patients with Hepatic Cirrhosis". EKB Journal Management System, 4, 3, 2014, 143-148. doi: 10.21608/aeji.2014.17193
Shawky, J., Khorshed, S., Labib, H. (2014). 'Urinary Neutrophil Gelatinase-Associated Lipocalin as Predictor for Development of Hepatorenal Syndrome in Patients with Hepatic Cirrhosis', EKB Journal Management System, 4(3), pp. 143-148. doi: 10.21608/aeji.2014.17193
Shawky, J., Khorshed, S., Labib, H. Urinary Neutrophil Gelatinase-Associated Lipocalin as Predictor for Development of Hepatorenal Syndrome in Patients with Hepatic Cirrhosis. EKB Journal Management System, 2014; 4(3): 143-148. doi: 10.21608/aeji.2014.17193

Urinary Neutrophil Gelatinase-Associated Lipocalin as Predictor for Development of Hepatorenal Syndrome in Patients with Hepatic Cirrhosis

Afro-Egyptian Journal of Infectious and Endemic Diseases
Article 5, Volume 4, Issue 3, September 2014, Page 143-148  XML PDF (400.23 K)
Document Type: Original Article
DOI: 10.21608/aeji.2014.17193
View on SCiNiTO View on SCiNiTO
Authors
Jihan A Shawky1; Soha E Khorshed1; Hany A Labib2
1Department of Tropical Medicine, Faculty of Medicine, Zagazig University, Egypt
2Department of Clinical Pathology, Faculty of Medicine, Zagazig University, Egypt
Abstract
Background and study aim: Liver cirrhosis has many complications, hepatorenal syndrome (HRS) is one of the most serious complications of it. Neutrophil gelatinase-associated lipocalin (NGAL) is a protein expressed by injured kidney tubular epithelia, urinary NGAL levels rise early in cases of acute kidney impairment before elevation of serum creatinine. The aim of this study is to evaluate NGAL as a biomarker for early detection of HRS in patients with hepatic cirrhosis.
Patients and methods: Seventy five patients were studied and divided into two groups, group (I) 50 patients with liver cirrhosis without impairment of kidney functions and group (II) 25 patients with cirrhosis and impaired kidney functions. Urinary NGAL level were measured by ELISA.
Results : The mean value of urinary NGAL level in patients with liver cirrhosis was 50 ± 33 ng/ml while in patients with cirrhosis and HRS was 750 ± 250 ng/ml which showed highly statistically significant difference between both groups of patients.
Conclusion : Urinary NGAL increases significantly in patients with liver cirrhosis associated with impairment of kidney function than in those with stable cirrhosis and normal kidney function, so it can be used as a marker for prediction of development of HRS in cirrhotic patients.
Keywords
Neutrophil gelatinase-associated lipocalin; Hepatorenal syndrome; Liver cirrhosis
Statistics
Article View: 170
PDF Download: 339